Skip to content

Medical-device intelligence

MST: Antibodies, Gliadin

FDA product code MST: Antibodies, Gliadin. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
MST
FDA device name
Antibodies, Gliadin
Device class
2
Regulation number
866.5750
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

42 clearance records and 3 recall records in the covered releases, across 19 source company names and 1 product codes. Dated history runs from May 30, 1997 to May 1, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
MST · Antibodies, Gliadin423

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

45 matching records
Device / recordCompany in FDA recordSourceSource date
EliA GliadinDP IgG Well in the Phadia 2500EE instrument (Material Number 12410002) EliA GliadinDP IgG is intended for the in vitro semi-quantitat…Z-2040-2023 · MSTPhadia US IncRecallJun 30, 2023FDA classification date
Phadia 2500EE instrument -Intended for the in vitro semi-quantitative measurement of IgG antibodies directed to gliadin in human serum or plasma …Z-2041-2023 · MSTPhadia US IncRecallJun 30, 2023FDA classification date
ImmuLisa Enhanced Gliadin IgA Antibody ELISA, ImmuLisa Enhanced Gliadin IgG Antibody ELISAK163177 · MSTImmco Diagnostics, Inc.510(k)Jul 28, 2017FDA decision date
AESKULISA DGP-A, AESKULISA DGP-G,AESKULISA DGP-CHECKK132082 · MSTAesku Diagnostics510(k)Dec 5, 2013FDA decision date
GLIADIN IGA AND GLIADIN LGAK113377 · MSTGrifols USA, LLC510(k)Dec 14, 2012FDA decision date
QUANTA FLASH DGP IGA, QUANTA FLASH DGP IGG, QUANTA FLASH DGP IGA CALIBRATORS, QUANTA FLASH DGP IGG CALIBRATORSK113863 · MSTInova Diagnostics, Inc.510(k)Sep 20, 2012FDA decision date
QUANTA FLASH (TM) DGP SCREENK111414 · MSTInova Diagnostics, Inc.510(k)Oct 20, 2011FDA decision date
ELIA GLIADIN DP IGA IMMUNOASSAY AND ELIA GLIADIN DP IGG IMMUNOASSAY, MODELS 14-5538-01, 14-5539-01K093459 · MSTPhadia US, Inc.510(k)Aug 13, 2010FDA decision date
IMMULISA CELIAC G+ (GLIADIN) IGA AND IGG ANTIBODY ELISAK091522 · MSTImmco Diagnostics, Inc.510(k)Feb 4, 2010FDA decision date
EUROIMMUN ANTI-GLIADIN (GAF-3X) ELISA (IGG)K083053 · MSTEuroimmun Us, Inc.510(k)Aug 7, 2009FDA decision date
EUROIMMUN ANTI-GLIADIN (GAF-3X) ELISA (IGA)K083052 · MSTEuroimmun Us, Inc.510(k)Jul 28, 2009FDA decision date
BINDAZYME HUMAN ANTI-GLIADIN (MGP), IGG EIA KIT; BINDAZYME HUMAN ANTI-GLIADIN (MGP) IGA EIA KIT; (IGA OR IGG)K081674 · MSTThe Binding Site, Ltd.510(k)Oct 15, 2008FDA decision date
Is-anti-Gliadin IgG Enzyme Immunoassay Test Kit packaged in cardboard boxes with individual components secured within a foam insert. Catalog Numb…Z-1684-2008 · MSTDiamedix CorporationRecallSep 16, 2008FDA classification date
ELIA GLIADIN IGA, IGG AND CELIAC CONTROLK063775 · MSTPhadia US, Inc.510(k)Mar 14, 2007FDA decision date
QUANTA LITE H-TTG/DGP SCREENK070083 · MSTInova Diagnostics, Inc.510(k)Mar 12, 2007FDA decision date
QUANTA LITE CELIAC DGP SCREENK062708 · MSTInova Diagnostics, Inc.510(k)Dec 13, 2006FDA decision date
FIDIS CELIACK053383 · MSTBiomedical Diagnostics (Bmd) SA510(k)Mar 29, 2006FDA decision date
AESKULISA GLIA A AND AESKULISA GLIA GK052439 · MSTAesku Diagnostics510(k)Feb 7, 2006FDA decision date
IMMUNOCAP/UNICAP GLIADIN IGA, IMMUNOCAP/UNICAP SPECIFIC IGA, MODELS 14-4425-40, 10-9306-02K052793 · MSTPharmacia Diagnostics AB510(k)Feb 7, 2006FDA decision date
QUANTA LITE GLIADIN IGG IIK052142 · MSTInova Diagnostics, Inc.510(k)Oct 4, 2005FDA decision date
QUANTA LITE GLIADIN IGA IIK052143 · MSTInova Diagnostics, Inc.510(k)Oct 4, 2005FDA decision date
FIDIS CELIACK041002 · MSTBiomedical Diagnostics S.A.510(k)Sep 24, 2004FDA decision date
VARELISA GLIADIN IGG ANTIBODIESK041357 · MSTSweden Diagnostics (Germany) GmbH510(k)Aug 2, 2004FDA decision date
VARELISA GLIADIN IGA ANTIBODIES MODEL #19848/19896K041354 · MSTSweden Diagnostics (Germany) GmbH510(k)Jul 16, 2004FDA decision date
DIAMEDIX IS-ANTI-GLIADIN IGG TEST SYSTEMK012795 · MSTDiamedix Corp.510(k)Sep 28, 2001FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗